Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis

Background and Objectives: Osteoprotegerin (OPG), a potent osteoclast activation inhibitor, decreases bone resorption and plays a role in mediating bone mineral density (BMD). Our aim was to evaluate the relationship between BMD and serum OPG in maintenance hemodialysis (MHD) patients. Materials and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chia-Wen, Wang, Chih-Hsien, Hsu, Bang-Gee, Tsai, Jen-Pi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399781/
https://www.ncbi.nlm.nih.gov/pubmed/34440966
http://dx.doi.org/10.3390/medicina57080762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399781/
https://www.ncbi.nlm.nih.gov/pubmed/34440966
http://dx.doi.org/10.3390/medicina57080762

Ejemplares similares